Programming Of Energy Metabolism In Prostate Carcinoma: In Silico Analysis
Öz
Prostate carcinoma is known to be a hypoxic and lipogenic solid tumor, exhibiting a remarkable oncogenic modulated metabolic programming. Increasing intake of glucose and aerobic glycolysis, called the Warburg effect, are main metabolic changes in hypoxic tumors. Protein,nucleid acid , and lipid biosynthesis are the other metabolic processes associated with cancer metabolic rewiring. In addition to “Warburg effect” in prostate carcinoma, fatty acids, glutamine, and mitochondrial oxidative phosphorylation in alternative metabolic pathways are considered main contributors to tumorigenesis. The aim of this study is to investigate reprogramming of energy metabolism in well and poorly differentiated prostate carcinomas with seminal vesical invasion. The GSE32448 gene’s microarray data were downloaded from the "Gene Expression OmniBus". Differences in gene expression levels were generated by re-analyzing the mRNA transcripts of tissues obtained from 40 patients specimens. "Biobase", "Limma" and "Geoquery" libraries were obtained with bioinformatics analysis using R program. Statistically significant differences were found in genes related to fatty acid metabolism. Increased awareness of the role of lipid metabolism in prostate cancer can lead to developing better treatment strategies against this malignancy.
Anahtar Kelimeler
Bioinformatic, Metabolic reprogramming, Molecular pathology, Prostate cancer
Kaynakça
- Darwiche, N. (2020). “Epigenetic mechanisms and the hallmarks of cancer: an intimate affair”. American journal of cancer research, 10 (7), 1954–1978.
- Kreuzaler, P, Panina, Y, Segal, J, Yuneva, M. (2020). “Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion”. Mol Metab, 33,83-101.
- Bhandari, V, Hoey, C, Liu, L et al. (2019). “Molecular landmarks of tumor hypoxia across cancer types”. Nat Genet, 51, 308–318.
- Frezza, C. (2020). “Metabolism and cancer: the future is now”. Br J Cancer, 122 (2),133-135.
- Zheng, J. (2012). “Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation”. Oncology Letters, 4, 1151-1157.
- Phan, L, Yeung, S, Lee, M. (2014). “Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies”. Cancer biology & medicine, 11 (1), 1–19.
- Petan, T, Jarc, E, Jusović, M. (2018). “Lipid Droplets in Cancer: Guardians of Fat in a Stressful World”. Molecules, 23 (8), 1941.
- Ma, Y, Temkin, S, Hawkridge, M, et al. (2018). “Fatty acid oxidation: An emerging facet of metabolic transformation in cancer”. Cancer letters, 435, 92-100.
- Kızılay, F, Çelik, S, Sözen, S. et al. (2020). “Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association”. Prostate international, 8 (1), 10–15.
- Deep, G, Schlaepfer, IR. (2016). “Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis”. Int J Mol Sci, 17 (7),1061.